ArticleBlood neoplasia2026

ctDNA for MRD assessment is prognostic and predictive in newly diagnosed and relapsed/refractory lymphoma.

Natalie Galanina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.